Home

Alexander A Fitzpatrick

CIK 1398595 · Chief Legal Officer · last filed 2026-06-12

Alexander A Fitzpatrick is a Chief Legal Officer who has filed 43 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for SPRY, was dated Jun 12, 2026. Across all open-market trades the lifetime net is −$1.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $432.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$432.7K

Companies

4

Total Filings

43

Lifetime Open-Market Net

-$1.10M

Filer Profile

Reported Address
9605 SCRANTON ROAD, SUITE 200
SAN DIEGO, CA 92121
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SPRY Chief Legal Officer 90,910 $4.76 $432.7K -$1.17M 7 2026-06-12
Evofem Biosciences, Inc. (EVFM) Delisted General Counsel and Secretary 275 $0.01 $2 $51.0K 25 2022-02-23
VERENIUM CORP (VRNM) Delisted Sr. VP General Counsel 7,496 — — $14.2K 5 2013-08-02
KINTERA INC (UNCL) Delisted SVP and General Counsel 0 — — $0 3 2008-07-10

Recent Filings

43 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-12 SPRY Notice (144) −3,355 -$33.5K EDGAR
2026-06-12 SPRY Sell (S) −3,355 -$33.5K EDGAR
2026-01-05 SPRY Grant (A) — $0 EDGAR
2025-05-22 SPRY Mixed −2,969 -$893.5K EDGAR
2025-05-20 SPRY Notice (144) −102,969 -$1.44M EDGAR
2025-01-03 SPRY Grant (A) — $0 EDGAR
2024-01-04 SPRY Grant (A) — $0 EDGAR
2023-10-02 SPRY Buy (P) +86,258 $320.0K EDGAR
2023-01-05 SPRY Grant (A) — $0 EDGAR
2022-02-23 Evofem Biosciences, Inc. (EVFM) Delisted Grant (A) +300,000 $0 EDGAR
Showing 1–10 of 43
Page 1 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.